Report Detail
Global Alosetron Market Insights, Forecast to 2025
- RnM3498628 |
- 06 June, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Alosetron (original brand name: Lotronex; originator: GSK) is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only. It is currently marketed by Prometheus Laboratories Inc. (San Diego). Alosetron was withdrawn from the market in 2000 owing to the occurrence of serious life-threatening gastrointestinal adverse effects, but was reintroduced in 2002 with availability and use restricted.
The global Alosetron market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alosetron market based on company, product type, end user and key regions.
This report studies the global market size of Alosetron in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alosetron in these regions.
This research report categorizes the global Alosetron market by top players/brands, region, type and end user. This report also studies the global Alosetron market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sebela Pharmaceuticals
Amneal
Par Pharmaceutical
West-Ward Pharmaceuticals
Market size by Product
0.5 Tablets
1 mg Tablets
Market size by End User
Hospital
Drugstore
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Alosetron market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alosetron market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alosetron companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alosetron submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Alosetron are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alosetron market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Alosetron Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Alosetron Market Size Growth Rate by Product
- 1.4.2 0.5 Tablets
- 1.4.3 1 mg Tablets
- 1.5 Market by End User
- 1.5.1 Global Alosetron Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Drugstore
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Alosetron Market Size
- 2.1.1 Global Alosetron Revenue 2014-2025
- 2.1.2 Global Alosetron Sales 2014-2025
- 2.2 Alosetron Growth Rate by Regions
- 2.2.1 Global Alosetron Sales by Regions
- 2.2.2 Global Alosetron Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Alosetron Sales by Manufacturers
- 3.1.1 Alosetron Sales by Manufacturers
- 3.1.2 Alosetron Sales Market Share by Manufacturers
- 3.1.3 Global Alosetron Market Concentration Ratio (CR5 and HHI)
- 3.2 Alosetron Revenue by Manufacturers
- 3.2.1 Alosetron Revenue by Manufacturers (2014-2019)
- 3.2.2 Alosetron Revenue Share by Manufacturers (2014-2019)
- 3.3 Alosetron Price by Manufacturers
- 3.4 Alosetron Manufacturing Base Distribution, Product Types
- 3.4.1 Alosetron Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Alosetron Product Type
- 3.4.3 Date of International Manufacturers Enter into Alosetron Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Alosetron Sales by Product
- 4.2 Global Alosetron Revenue by Product
- 4.3 Alosetron Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Alosetron Breakdown Data by End User
6 North America
- 6.1 North America Alosetron by Countries
- 6.1.1 North America Alosetron Sales by Countries
- 6.1.2 North America Alosetron Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Alosetron by Product
- 6.3 North America Alosetron by End User
7 Europe
- 7.1 Europe Alosetron by Countries
- 7.1.1 Europe Alosetron Sales by Countries
- 7.1.2 Europe Alosetron Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Alosetron by Product
- 7.3 Europe Alosetron by End User
8 Asia Pacific
- 8.1 Asia Pacific Alosetron by Countries
- 8.1.1 Asia Pacific Alosetron Sales by Countries
- 8.1.2 Asia Pacific Alosetron Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Alosetron by Product
- 8.3 Asia Pacific Alosetron by End User
9 Central & South America
- 9.1 Central & South America Alosetron by Countries
- 9.1.1 Central & South America Alosetron Sales by Countries
- 9.1.2 Central & South America Alosetron Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Alosetron by Product
- 9.3 Central & South America Alosetron by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Alosetron by Countries
- 10.1.1 Middle East and Africa Alosetron Sales by Countries
- 10.1.2 Middle East and Africa Alosetron Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Alosetron by Product
- 10.3 Middle East and Africa Alosetron by End User
11 Company Profiles
- 11.1 Sebela Pharmaceuticals
- 11.1.1 Sebela Pharmaceuticals Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Sebela Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Sebela Pharmaceuticals Alosetron Products Offered
- 11.1.5 Sebela Pharmaceuticals Recent Development
- 11.2 Amneal
- 11.2.1 Amneal Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Amneal Alosetron Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Amneal Alosetron Products Offered
- 11.2.5 Amneal Recent Development
- 11.3 Par Pharmaceutical
- 11.3.1 Par Pharmaceutical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Par Pharmaceutical Alosetron Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Par Pharmaceutical Alosetron Products Offered
- 11.3.5 Par Pharmaceutical Recent Development
- 11.4 West-Ward Pharmaceuticals
- 11.4.1 West-Ward Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 West-Ward Pharmaceuticals Alosetron Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 West-Ward Pharmaceuticals Alosetron Products Offered
- 11.4.5 West-Ward Pharmaceuticals Recent Development
12 Future Forecast
- 12.1 Alosetron Market Forecast by Regions
- 12.1.1 Global Alosetron Sales Forecast by Regions 2019-2025
- 12.1.2 Global Alosetron Revenue Forecast by Regions 2019-2025
- 12.2 Alosetron Market Forecast by Product
- 12.2.1 Global Alosetron Sales Forecast by Product 2019-2025
- 12.2.2 Global Alosetron Revenue Forecast by Product 2019-2025
- 12.3 Alosetron Market Forecast by End User
- 12.4 North America Alosetron Forecast
- 12.5 Europe Alosetron Forecast
- 12.6 Asia Pacific Alosetron Forecast
- 12.7 Central & South America Alosetron Forecast
- 12.8 Middle East and Africa Alosetron Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Alosetron Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Alosetron . Industry analysis & Market Report on Alosetron is a syndicated market report, published as Global Alosetron Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Alosetron market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
